Skip to main content
. 2022 Dec 16;110(3):313–321. doi: 10.1111/ejh.13908

FIGURE 3.

FIGURE 3

The 5‐year survival according to median value of CD163 (<24 and ≥24 positively stained cells per HPF). (A) All patients; (B) Patients with NSAA at diagnosis; (C) Patients with SAA at diagnosis; (D) Patients with VSAA at diagnosis